Abstract
High throughput screening of the corporate compound collection led to the identification of a novel series of 2-amino-9-aryl-3-cyano-4-methyl-7-oxo-6,7,8,9-tetrahydropyrido[2',3':4,5]thieno[2,3-b]pyridine derivatives as selective PR agonists. Initial SAR exploration leading to potent and selective agonists 9 and 11, X-ray crystal structure of 9 bound to PR-LBD and preliminary developability data are described.
MeSH terms
-
Animals
-
Binding Sites
-
Computer Simulation
-
Crystallography, X-Ray
-
Humans
-
Microsomes, Liver / metabolism
-
Molecular Conformation
-
Pyridines / chemical synthesis
-
Pyridines / chemistry*
-
Pyridines / pharmacology
-
Pyridones / chemical synthesis
-
Pyridones / chemistry*
-
Pyridones / pharmacology
-
Rats
-
Receptors, Progesterone / agonists*
-
Receptors, Progesterone / metabolism
-
Structure-Activity Relationship
-
Thiophenes / chemical synthesis
-
Thiophenes / chemistry*
-
Thiophenes / pharmacology
Substances
-
Pyridines
-
Pyridones
-
Receptors, Progesterone
-
Thiophenes